IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).
在北欧地尔硫卓（NORDIL）研究和综合影像和生物标志物研究 3（IBIS-3）中，IgM 抗丙二醛低密度脂蛋白抗体水平指示冠心病和坏死核心特征
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2018.08.023
van den Berg Victor J, Haskard Dorian O, Fedorowski Artur, Hartley Adam, Kardys Isabella, Caga-Anan Mikhail, Akkerhuis K Martijn, Oemrawsingh Rohit M, van Geuns Robert Jan, de Jaegere Peter, van Mieghem Nicolas, Regar Evelyn, Ligthart Jurgen M R, Umans Victor A W M, Serruys Patrick W, Melander Olle, Boersma Eric, Khamis Ramzi Y
